-
s Compelling Indications Should be Listed for Individual Beta-Blockers (Due to Diversity), Not for the Whole Class
- Source: Current Vascular Pharmacology, Volume 19, Issue 4, Jul 2021, p. 343 - 346
-
- 01 Jul 2021
Preview this article:




Compelling Indications Should be Listed for Individual Beta-Blockers (Due to Diversity), Not for the Whole Class, Page 1 of 1
< Previous page Next page > /docserver/preview/fulltext/cvp/19/4/s2-1.gif
There is no abstract available.
© Bentham Science Publishers